PubMed COVID-19 Clinical Care

This research focuses on the design of a novel fractional model for simulating the ongoing spread of the coronavirus (COVID-19). The model is composed of multiple categories named susceptible [Formula: see text], infected [Formula: see text], treated

No abstract

The coronavirus disease 2019 (COVID-19) aftermath left an alarming surge in syphilis cases, contradicting the previously stable trajectory of the infection. US Centers for Disease Control and Prevention also reported a 38% increase in primary and

On January 20, 2023, the Japanese government announced easing the legal handling of the novel coronavirus disease 2019 (COVID-19) under its Infectious Diseases Control Act, effective May 8, 2023. While free vaccines will continue in fiscal year 2023

CONCLUSIONS: While limitations existed, this study provides insights into sustaining care during crises, highlighting the importance of innovative healthcare delivery methods and age-sensitive approaches for PLWH.

No abstract

No abstract

Background Coronavirus disease 2019 (COVID-19) is a major public health problem worldwide, and vaccination is currently the most effective way to control its spread and reduce its severity. Diabetes mellitus (DM) is a prevalent chronic disease that

The Covid-19 pandemic has highlighted the precarity of urban society, illustrating both opportunities and challenges. Teleworking rates increased dramatically during the pandemic and may be sustained over the long term. For transportation planners

CD24 has emerged as a molecule of significant interest beyond the oncological arena. Recent studies have unveiled its surprising and diverse roles in various biological processes and diseases. This review encapsulates the expanding spectrum of CD24